Therefore, based on the hypothesis that cGAS/STING pathway-mediated activation of the IFN machinery exerts cytotoxic effects on CML LSC, we investigated the effect of olaparib on activation of the cGAS/STING pathway. This evidence concerns the gene STING1 and chronic myelogenous leukemia, BCR-ABL1 positive.